STACK DAVID M
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to STACK DAVID M. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PCRX | CEO and Chairman | Award / Grant | 32,700 | — | — | Jun 14, 2023 |
| PCRX | CEO and Chairman | Sale | 5,058 | $38.99 | $197,211 | Jun 7, 2023 |
| PCRX | CEO and Chairman | Sale | 5,006 | $60.33 | $302,012 | Jun 6, 2022 |
| PCRX | CEO and Chairman | Option Exercise | 22,500 | $10.81 | $243,225 | Apr 28, 2022 |
| PCRX | CEO and Chairman | Option Exercise | 22,500 | $10.81 | $243,225 | Mar 31, 2022 |
| PCRX | CEO and Chairman | Option Exercise | 13,670 | $10.81 | $147,773 | Jan 25, 2022 |
| PCRX | CEO and Chairman | Option Exercise | 15,000 | $10.81 | $162,150 | Jan 11, 2022 |
| PCRX | CEO and Chairman | Option Exercise | 15,000 | $10.81 | $162,150 | Nov 16, 2021 |
| 0001339469 | Disposition | 25,000 | — | — | Aug 5, 2021 | |
| PCRX | CEO and Chairman | Award / Grant | 17,800 | — | — | Jun 9, 2021 |
| PCRX | CEO and Chairman | Sale | 14,905 | $61.04 | $909,801 | Jun 4, 2021 |
| AMRN | Purchase | 10,000 | $4.54 | $45,400 | Jun 3, 2021 | |
| PCRX | CEO and Chairman | Gift | 1,080 | — | — | May 11, 2021 |
| PCRX | CEO and Chairman | Sale | 14,350 | $71.42 | $1,024,877 | Feb 3, 2021 |
| AMRN | Purchase | 25,000 | $4.86 | $121,500 | Nov 30, 2020 | |
| 0001339469 | Purchase | 25,000 | $4.27 | $106,750 | Nov 30, 2020 | |
| PCRX | CEO and Chairman | Option Exercise | 30,000 | $10.81 | $324,300 | Oct 14, 2020 |
| PCRX | CEO and Chairman | Sale | 3,217 | $62.34 | $200,548 | Aug 17, 2020 |
| PCRX | CEO and Chairman | Sale | 12,000 | $56.88 | $682,560 | Jul 15, 2020 |
| PCRX | CEO and Chairman | Award / Grant | 33,300 | — | — | Jun 9, 2020 |
| PCRX | CEO and Chairman | Sale | 15,390 | $48.08 | $739,951 | Jun 8, 2020 |
| PCRX | CEO and Chairman | Option Exercise | 16,356 | $5.49 | $89,794 | Feb 21, 2020 |
| PCRX | CEO and Chairman | Sale | 1,975 | $43.48 | $85,873 | Jan 15, 2020 |
| PCRX | CEO and Chairman | Option Exercise | 10,000 | $5.49 | $54,900 | Dec 26, 2019 |
| PCRX | CEO and Chairman | Sale | 25,000 | $42.81 | $1,070,250 | Nov 15, 2019 |
| PCRX | CEO and Chairman | Option Exercise | 7,000 | $1.61 | $11,270 | Oct 2, 2019 |
| PCRX | CEO and Chairman | Option Exercise | 6,500 | $5.49 | $35,685 | Sep 18, 2019 |
| PCRX | CEO and Chairman | Sale | 10,458 | $39.05 | $408,385 | Aug 15, 2019 |
| AMRN | Option Exercise | 23,144 | $2.50 | $57,860 | Jul 11, 2019 | |
| PCRX | CEO and Chairman | Sale | 700 | $43.42 | $30,394 | Jul 8, 2019 |
| PCRX | CEO and Chairman | Option Exercise | 15,000 | $1.61 | $24,150 | Jun 11, 2019 |
| PCRX | CEO and Chairman | Sale | 12,385 | $42.91 | $531,440 | Jun 5, 2019 |
| AMRN | Option Exercise | 33,799 | $3.21 | $108,495 | May 29, 2019 | |
| AMRN | Option Exercise | 13,174 | $3.21 | $42,289 | May 17, 2019 | |
| AMRN | Option Exercise | 21,146 | $3.06 | $64,707 | Jan 10, 2019 | |
| PCRX | CEO and Chairman | Option Exercise | 6,000 | $5.49 | $32,940 | Dec 18, 2018 |
| PCRX | CEO and Chairman | Sale | 4,558 | $47.70 | $217,417 | Nov 15, 2018 |
| PCRX | CEO and Chairman | Option Exercise | 11,810 | $1.61 | $19,014 | Oct 11, 2018 |
| PCRX | CEO and Chairman | Option Exercise | 13,481 | $10.81 | $145,730 | Aug 15, 2018 |
| PCRX | CEO and Chairman | Award / Grant | 28,375 | — | — | Jun 13, 2018 |
| PCRX | CEO and Chairman | Sale | 2,600 | $37.53 | $97,578 | Jun 7, 2018 |
| PCRX | CEO and Chairman | Sale | 21,106 | $33.69 | $711,061 | May 15, 2018 |
| PCRX | CEO and Chairman | Sale | 4,628 | $41.03 | $189,887 | Jan 10, 2018 |
| PCRX | CEO and Chairman | Sale | 1,900 | $38.97 | $74,043 | Nov 15, 2017 |
| PCRX | CEO and Chairman | Sale | 28,885 | $36.37 | $1,050,547 | Aug 15, 2017 |
| PCRX | CEO and Chairman | Option Exercise | 15,000 | $1.61 | $24,150 | Jul 24, 2017 |
| PCRX | CEO and Chairman | Option Exercise | 15,000 | $1.61 | $24,150 | Jun 23, 2017 |
| PCRX | CEO and Chairman | Award / Grant | 40,500 | — | — | Jun 14, 2017 |
| PCRX | CEO and Chairman | Sale | 4,311 | $43.32 | $186,753 | Jun 5, 2017 |
| PCRX | CEO and Chairman | Sale | 1,300 | $38.81 | $50,453 | Jan 17, 2017 |